Skip to main content
PH

Predictably Human

This company develops a precision therapeutic platform that delivers coordinated, personalized therapies for complex disorders like mental health and addiction. Their core offering integrates an individualized, adaptive drug delivery device with a personalized digital companion application. The platform leverages cloud-based AI and data analytics to inform population-level personalization for precise, integrated treatment.

Boston, United StatesFounded 20227300+ followers
Updated 4 months ago

Funding

$7.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current treatments for mental health and substance use disorders often prove ineffective due to their failure to address individual patient needs in a coordinated and adaptive manner. Existing approaches lack the integration of physiological and psychological care, resulting in suboptimal outcomes.

Solution

Predictably Human's NoMore platform integrates precision drug delivery with a mobile app, leveraging cloud-based AI and data analytics to provide personalized treatment for chronic diseases and addiction, starting with nicotine dependence. The platform delivers coordinated, adaptive therapies tailored to individual patient needs. By combining these technologies, NoMore aims to create an ecosystem of digital products and services that improve the lives of patients with mental health, addiction, and other complex disorders. The system integrates physiological and psychological care to provide a more sophisticated solution.

Target Audience

The primary target audience includes individuals suffering from chronic diseases and addiction, particularly nicotine dependence, as well as healthcare providers seeking more effective and personalized treatment options.

Features

  • Precision drug delivery system for controlled medication administration.
  • Companion mobile app for patient engagement and data collection.
  • Cloud-based AI and data analytics for personalized treatment plans.
  • Adaptive therapy adjustments based on real-time patient data.
  • Integration of physiological and psychological care components.
This profile is AI-generated and may contain inaccuracies.